Isabel Boivin

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

TP53-mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition.

TP53-mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition.

Journal: Science advances
Published: May 15, 2026

CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy.

CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 24, 2025

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.

Journal: Biomarker research
Published: November 06, 2024

DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition.

DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition.

Journal: EMBO reports
Published: October 09, 2024

SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.

SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.

Journal: Science advances
Published: March 22, 2024

Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.

Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.

Journal: Leukemia
Published: December 12, 2023

Immunotherapeutic targeting of surfaceome heterogeneity in AML.

Immunotherapeutic targeting of surfaceome heterogeneity in AML.

Journal: Cell reports
Published: October 05, 2023

DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AML.

DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AML.

Journal: Leukemia
Published: May 29, 2023

Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.

Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.

Journal: Blood advances
Published: August 30, 2021

HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.

HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.

Journal: Blood advances
Published: July 26, 2021

HLF expression defines the human hematopoietic stem cell state.

HLF expression defines the human hematopoietic stem cell state.

Journal: Blood
Published: January 08, 2021

High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.

High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.

Journal: Blood
Published: September 16, 2019
Showing 1-12 of 21

Last Updated: 09/26/2026